LOG IN

Cleveland BioLabs, Inc.

Versiunea din 24 noiembrie 2024 19:10, autor: 127.0.0.1 (discuție) (The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).)
(dif) ← Versiunea anterioară | Versiunea curentă (dif) | Versiunea următoare → (dif)

Pagina dedicata companiei Cleveland BioLabs, Inc. listata cu simbolul US.CBLI

Descriere companieModificare

Cleveland BioLabs Inc (www.cbiolabs.com) is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in the mitigation of radiation injury and immuno-oncology. Its lead product candidate is entolimod, an immuno-stimulatory agent, which is developed as a radiation countermeasure and immunotherapy for oncology and other indications. Entolimod is a Toll-like receptor 5 (TLR5) agonist, which is developed as a radiation countermeasure for the prevention of death from Acute Radiation Syndrome (ARS), and as an oncology drug.

Grafic actiuni companieModificare

Ultimele stiri despre Cleveland BioLabs, Inc. (US.CBLI)Modificare

Adus de la „https://wiki.tradeville.ro/index.php?title=Cleveland_BioLabs,_Inc.&oldid=529501”